Glycine

Manufacturer
ICU Medical Inc.
Effective date
2025-10-21
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
9
Source
monthly-update
Hydrated at
2026-07-17 21:38:12

Label at a glance#

ProductGlycine
Active ingredientGLYCINE
Label structure13 sections

Indications and uses

1.5% Glycine Irrigation, USP is indicated for use as irrigating fluid during transurethral prostatic resection and other transurethral surgical procedures.

Dosage and administration

1.5% Glycine Irrigation, USP should be administered only by transurethral instillation with appropriate urologic instrumentation. A disposable irrigation set should be used. The total volume of solution used for irrigation is solely at the discretion of the surgeon. Height of container(s) above the operating table in excess of 60 cm (approx. 2 ft.) has been reported to increase intravascular absorption of the irri...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

NONELECTROLYTE IRRIGATING FLUID FOR TRANSURETHRAL SURGICAL PROCEDURES.

For Urologic Irrigation Only; Not For Injection By Usual Parenteral Routes

Flexible Irrigation Container

Rx only

DESCRIPTION

DESCRIPTION SECTION

1.5% Glycine Irrigation, USP is a sterile, nonpyrogenic, hypotonic, aqueous solution of glycine intended only for urologic irrigation during transurethral surgical procedures.

Each 100 mL contains 1.5 g of glycine in water for injection. The solution is nonelectrolytic, hypotonic and has an osmolarity of 200 mOsmol/liter (calc.); pH 6.0 (4.5 to 6.5).

The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only for use as a single-dose irrigation. When smaller volumes are required, the unused portion should be discarded.

1.5% Glycine Irrigation is a urologic nonelectrolyte irrigant.

Glycine, USP is chemically designated aminoacetic acid (C2H5NO2), a white crystalline powder freely soluble in water. It has the following structural formula:

NH2CH2COOH

Water for Injection, USP is chemically designated H20.

The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly.

The semi-rigid container is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The container requires no vapor barrier to maintain the proper drug concentration.

The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C/77°F during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Glycine is an amino acid and a nonelectrolyte. A solution of glycine in water is therefore nonconductive and suitable for urologic irrigation during electrosurgical procedures. A 1.5% concentration of glycine in water (200 mOsmol/liter calc.) is sufficient to minimize the risk of intravascular hemolysis which can occur from absorption of plain water through open prostatic veins during transurethral resection (TUR). It is hypotonic in relation to the extracellular fluid (280 mOsmol/liter). Any solution absorbed intravascularly during transurethral prostatic or bladder surgery, although variable in amount depending primarily on the extent of surgery, will be excreted by the kidney. Studies have shown that the absorption of glycine does not cause significant hemolysis (increase of free hemoglobin) or release significant amounts of free ammonia in the blood. Glycine is rapidly degraded in the liver by glycine oxidase.

Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production).

Water balance is maintained by various regulatory mechanisms. Water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

1.5% Glycine Irrigation, USP is indicated for use as irrigating fluid during transurethral prostatic resection and other transurethral surgical procedures.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

NOT FOR INJECTION BY USUAL PARENTERAL ROUTES.

Do not use in patients with anuria.

WARNINGS

WARNINGS SECTION

FOR UROLOGIC IRRIGATION ONLY.

Solutions for urologic irrigation must be used with caution in patients with severe cardiopulmonary or renal dysfunction. Irrigating fluids used during transurethral prostatectomy have been demonstrated to enter the systemic circulation in relatively large volumes. Thus, glycine irrigating solution must be regarded as a systemic drug. Absorption of large amounts of fluids containing glycine may significantly alter cardiopulmonary and renal dynamics.

Do not heat container over 66°C (150°F).

PRECAUTIONS

PRECAUTIONS SECTION

Cardiovascular status, especially of the patient with cardiac disease, should be carefully observed before and during transurethral resection of the prostate when using glycine irrigating solution, because the quantity of fluid absorbed into the systemic circulation by opened prostatic veins may produce significant expansion of the extracellular fluid and lead to fulminating congestive heart failure. Shift of sodium free intracellular fluid into the extracellular compartment following systemic absorption of solution may lower serum sodium concentration and aggravate pre-existing hyponatremia.

Care should be exercised if impaired liver function is known or suspected. Under such conditions, ammonia resulting from metabolism of glycine may accumulate in the blood.

Aseptic technique is essential with the use of sterile solutions for irrigation. The administration set should be attached promptly. Unused portions should be discarded and a fresh container of appropriate size used for the start-up of each cycle or repeat procedure.

Do not administer unless solution is clear, seal is intact and container is undamaged. Discard unused portion.

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Carcinogenesis, Mutagenesis, Impairment of Fertility: Studies with Glycine Irrigation, USP have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.

NURSING MOTHERS SECTION

Nursing Mothers: Caution should be exercised when Glycine Irrigation, USP is administered to a nursing woman.

PREGNANCY SECTION

Pregnancy: Teratogenic Effects.

Pregnancy Category C. Animal reproduction studies have not been conducted with Glycine Irrigation, USP. It is also not known whether Glycine Irrigation, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Glycine Irrigation, USP should be given to a pregnant woman only if clearly needed.

PEDIATRIC USE SECTION

Pediatric Use: The safety and effectiveness of Glycine Irrigation have not been established. Its limited use in pediatric patients has been inadequate to fully define proper dosage and limitations for use.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Adverse reactions may result from intravascular absorption of glycine. Large intravenous doses of glycine are known to cause salivation, nausea and lightheadedness. Other consequences of absorption of urologic irrigating solutions include fluid and electrolyte disturbances such as acidosis, electrolyte loss, marked diuresis, urinary retention, edema, dryness of mouth, thirst, dehydration, coma from hyponatremia, secondary hyponatremia due to fluid overload, and hyperammonemia with resultant coma and/or encephalopathy; cardiovascular disorders such as hypotension, tachycardia, angina-like pains; pulmonary disorders such as pulmonary congestion; and other general reactions such as blurred vision, convulsions, nausea, vomiting, rhinitis, chills, vertigo, backache, transient blindness and urticaria. Allergic reactions from glycine are unknown or exceedingly rare.

Should any adverse reaction occur, discontinue the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

OVERDOSAGE

OVERDOSAGE SECTION

In the event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See WARNINGS, PRECAUTIONS and ADVERSE REACTIONS.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

1.5% Glycine Irrigation, USP should be administered only by transurethral instillation with appropriate urologic instrumentation. A disposable irrigation set should be used. The total volume of solution used for irrigation is solely at the discretion of the surgeon.

Height of container(s) above the operating table in excess of 60 cm (approx. 2 ft.) has been reported to increase intravascular absorption of the irrigating fluid.

Drug Interactions

Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution container permits. See PRECAUTIONS.

HOW SUPPLIED

HOW SUPPLIED SECTION

1.5% Glycine Irrigation, USP is supplied in single-dose 3000 mL flexible irrigation container

NDC No.ProductContainer Size (mL)
0409-7974-081.5% Glycine Irrigation, USP3000 mL
0990-7974-081.5% Glycine Irrigation, USP3000 mL

ICU Medical is transitioning NDC codes from the "0409" to a "0990" labeler code. Both NDC codes are expected to be in the market for a period of time.

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

Revised: November, 2022

ICU Medical, Inc., Lake Forest, Illinois, 60045, USA

IFU0000478

PRINCIPAL DISPLAY PANEL - 3000 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

3000 mL
NDC 0990-7974-08

1.5% GLYCINE
IRRIGATION, USP

EACH 100 mL CONTAINS GLYCINE
(AMINOACETIC ACID) 1.5 g.
pH 6.0 (4.5 TO 6.5)
200 mOsmol/LITER (CALC.)
STERILE, NONPYROGENIC,
HYPOTONIC.

INDICATIONS:
FOR UROLOGIC IRRIGATION.

CONTRAINDICATIONS:
NOT FOR INJECTION. USE ONLY IF
SOLUTION IS CLEAR AND
CONTAINER IS UNDAMAGED.

WARNINGS:
DO NOT HEAT OVER 66°C (150°F)
OR STORE ABOVE 40°C (104°F).
SINGLE-DOSE CONTAINER.
CONTAINS NO BACTERIOSTAT.
DISCARD UNUSED PORTION. USE
ASEPTIC TECHNIQUE.

USUAL DOSAGE:
SEE INSERT.

RX ONLY

3
V
CONTAINS DEHP

IM-4381

ICU Medical, Inc.,
Lake Forest, Illinois, 60045, USA

icumedical

PRINCIPAL DISPLAY PANEL - 3000 mL Bag Label
PRINCIPAL DISPLAY PANEL - 3000 mL Bag Label

PRINCIPAL DISPLAY PANEL - Overwrap Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

2
HDPE

TO OPEN TEAR AT NOTCH

DO NOT REMOVE FROM OVERWRAP UNTIL READY FOR USE. AFTER REMOVING
THE OVERWRAP, CHECK FOR MINUTE LEAKS BY SQUEEZING CONTAINER FIRMLY.
IF LEAKS ARE FOUND, DISCARD SOLUTION AS STERILITY MAY BE IMPAIRED.
RECOMMENDED STORAGE: ROOM TEMPERATURE (25°C). AVOID EXCESSIVE
HEAT. PROTECT FROM FREEZING. SEE INSERT.
98-4321-R14-3/98

PRINCIPAL DISPLAY PANEL - Overwrap Label
PRINCIPAL DISPLAY PANEL - Overwrap Label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0990-7974-08ML - Milliliter0990-79748f3c9366-f88d-4c88-830f-dcf410f0adae12020-01-03

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0990-79740990-7974-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
GLYCINETE7660XO1CACTIB
WATER059QF0KO0RIACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
82025-10-21full-release2026-05-31 22:02:44
62023-04-14full-release2026-05-31 20:48:37

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N018315-001GLYCINE 1.5% IN PLASTIC CONTAINERGLYCINE1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N018315-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982c2088c7a36db…
2026-09-14 22:38:342026-08N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 198284e616aacf4f…
2026-08-18 06:07:402026-07N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N018315-001GLYCINE 1.5% IN PLASTIC CONTAINER1.5GM/100MLSOLUTION / IRRIGATIONATApproved before 19823a93d1ddd44b…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-10-15 13:18:302026-09N018315-001AT1c2088c7a36db…
2026-09-14 22:38:342026-08N018315-001AT184e616aacf4f…
2026-08-18 06:07:402026-07N018315-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N018315-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018315-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08N018315-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018315-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N018315-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N018315-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N018315-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N018315-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N018315-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N018315-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N018315-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N018315-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N018315-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N018315-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N018315-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N018315-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N018315-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N018315-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N018315-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N018315-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N018315-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03N018315-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N018315-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N018315-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N018315-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09N018315-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07N018315-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N018315-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N018315-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N018315-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N018315-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N018315-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N018315-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N018315-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05N018315-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01N018315-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N018315-001AT13a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GlycineGLYCINEICU Medical Inc.c10a4657-cf64-4a71-a247-363dd58993bc2025-10-21Warnings, Adverse reactionsExact identifier
ndc (package): 0990-7974-08
ndc (product): 0990-7974
ndc11 (package): 00990797408
spl id: fec5845c-710f-4a36-8d95-823471210c8a
spl set id: c10a4657-cf64-4a71-a247-363dd58993bc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.